BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

PBPHvsFHLCETF Comparison

ETF 1

PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of

DM Large & Mid Cap

+0.15%

Full PBPH fund page

VS

ETF 2

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

-0.15%

Full FHLC fund page

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. Fidelity MSCI Health Care Index ETF (FHLC) is part of the US Health Care segment. PBPH's top 3 sector exposures are Health Care and Consumer Staples. In contrast, FHLC's top sector exposures are Health Care PBPH is more expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.084% for FHLC. PBPH is up 1.62% year-to-date (YTD) with +$830M in YTD flows. FHLC performs worse with -0.33% YTD performance, and +$224M in YTD flows. Run a side-by-side ETF comparison of PBPH and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

PBPH vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 06/16/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	PBPH FHLC	+3.39%+5.45%	-0.01%+2.79%	+1.62%-0.33%	n/a+16.43%	n/a+22.09%	n/a+26.09%
Flows	PBPH FHLC	+$15M+$25M	+$95M+$113M	+$830M+$224M	-+$223M	--$413M	--$78M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	PBPH FHLC	+17.23%+16.20%	n/a+14.77%	n/a+14.02%	n/a+15.05%
Max drawdown	PBPH FHLC	-5.84%-4.50%	n/a-10.35%	n/a-16.88%	n/a-17.78%
Max drawdown duration	PBPH FHLC	56d22d	n/a159d	n/a435d	n/a762d

Trading data

Create an account to view trading data

Join for free

	PBPH	FHLC
Last sale 6/17/2026 at 1:30 PM	$25.60	$72.87
Previous close 06/16/2026	$25.67	$73.77
Consolidated volume 06/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of May 29, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	PBPH	FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 6/17/2026 at 1:30 PM

Live

Closed

	PBPH	FHLC
Last price	$25.60	$72.87
1D performance	-0.27%	-1.22%
AuM	$802.32 M	$3.05 B
E/R	0.13%	0.084%

Characteristics

	PBPH	FHLC
Management strategy	Passive	Passive
Provider	Tidal	Fidelity
Benchmark	BITA Global Pharma and Biotech Select Index	MSCI USA IMI Health Care 25/50 Index
N° of holdings	49	281
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	November 24, 2025	October 21, 2013
ESG	No	No

More PBPH data on Trackinsight

More FHLC data on Trackinsight

Exposure

Countries

PBPH

USA

62.04%

Other

37.96%

FHLC

USA

96.36%

Other

3.64%

Sectors

PBPH

Health Care

88.29%

Other

11.71%

FHLC

Health Care

97.13%

Other

2.87%

Diversification

PBPH

Total weight of top 15 holdings out of 15

67.47%

FHLC

Total weight of top 15 holdings out of 15

59.56%

Top 15 holdings

Data as of April 30, 2026

PBPH

LILLY

12.31%

JOHNSON&JOHNSON

9.12%

ABBVIE

5.86%

NOVARTIS

4.60%

MERCK & CO INC

4.57%

AMGEN-T

4.35%

GILEAD SCIENCES

4.23%

PFIZER

4.06%

NOVO-NORDISK

3.52%

BRISTOL-MYERS SQUIBB

3.13%

VERTEX PHARMACEUTICALS

2.88%

GSK PLC

2.73%

SANOFI SA

2.69%

REGENERON PHARMACEUTICALS

2.03%

CSL

1.39%

FHLC

LILLY

11.43%

JOHNSON&JOHNSON

8.89%

ABBVIE

5.71%

UNITEDHEALTH GRP

5.26%

MERCK & CO INC

4.48%

AMGEN-T

3.00%

THERMO FISHER SCIENTIFIC

2.88%

INTUITIVE SURGICAL

2.73%

ABBOTT LABS

2.64%

GILEAD SCIENCES

2.60%

PFIZER

2.49%

BRISTOL-MYERS SQUIBB

1.93%

DANAHER

1.88%

STRYKER

1.85%

VERTEX PHARMACEUTICALS

1.77%

Frequently asked questions about PBPH and FHLC

PBPHvsFHLCETF Comparison

Portfolio Building Block World Pharma and Biotech Index ETF

Fidelity MSCI Health Care Index ETF

PBPH vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the PBPH and FHLC ETFs performed in 2026?

As of June 16, 2026, PBPH is up 1.62% year-to-date (YTD), while FHLC has lost -0.33%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or FHLC?

Year-to-date, the PBPH ETF saw +$830M in flows, compared to +$224M for FHLC.

Which ETF is bigger: PBPH or FHLC?

As of June 16, 2026, PBPH holds $802.32 M in assets under management (AUM), while FHLC manages $3.05 B.

What sectors do the PBPH and FHLC ETFs invest in?

PBPH leans toward sectors like Health Care. Meanwhile, FHLC focuses on Health Care.

What are the top holdings of the PBPH ETF and FHLC ETF?

PBPH top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. FHLC holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: PBPH or FHLC?

PBPH holds 49 securities with 67.47% of its assets in the top 15. FHLC has 336 securities and a top 15 weight of 59.56%.

Build and Analyze Your ETF Portfolio Like a Pro